CLINICAL_TRIALS
trial_result
· 2016-05-03
Clinical Trial Update: PROMUS Element Plus US Post-Approval Study [Phase 4]
Summary
Phase 4 post-approval study of the PROMUS Element Plus coronary stent completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boston Scientific Corporation | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2016-05-03